HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Agnieszka Ulaczyk-Lesanko Selected Research

2- ((3,5- bis(trifluoromethylphenyl))hydroxymethyl)- 2- (4- nitrophenylamino)- 6- phenyl- 1,2,4a,7a- tetrahydropyrrolo(3,4- b)pyridine- 5,7- dione

9/2008A small-molecule compound identified through a cell-based screening inhibits JAK/STAT pathway signaling in human cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Agnieszka Ulaczyk-Lesanko Research Topics

Disease

1Adenocarcinoma
10/2009
1Carcinoma (Carcinomatosis)
10/2009
1Hodgkin Disease (Hodgkin's Disease)
09/2008
1Neoplasms (Cancer)
09/2008

Drug/Important Bio-Agent (IBA)

1Small Interfering RNA (siRNA)IBA
10/2009
12- (1- hydroxyundecyl)- 1- (4- nitrophenylamino)- 6- phenyl- 6,7a- dihydro- 1H- pyrrolo(3,4- b)pyridine- 5,7(2H,4aH)- dioneIBA
10/2009
1A-factor (Streptomyces)IBA
10/2009
12- ((3,5- bis(trifluoromethylphenyl))hydroxymethyl)- 2- (4- nitrophenylamino)- 6- phenyl- 1,2,4a,7a- tetrahydropyrrolo(3,4- b)pyridine- 5,7- dioneIBA
09/2008
1Tyrosine (L-Tyrosine)FDA Link
09/2008